Showing results (251-260 of 270) with videos related to

Sort By:
Pageof 27
Lung Cancer (Amsterdam, Netherlands)|January 3, 2025
Exploring machine learning tools in a retrospective case-study of patients with metastatic non-small cell lung cancer treated with first-line immunotherapy: A feasibility single-centre experienceFrancesca Rita Ogliari, Alberto Traverso, Simone Barbieri, et al.
Respiratory Medicine|October 4, 2016
Effects of omalizumab in severe asthmatics across ages: A real life Italian experienceB Sposato, M Scalese, M Latorre, et al.
Elife|January 8, 2025
Yerba mate (Ilex paraguariensis) genome provides new insights into convergent evolution of caffeine biosynthesisFederico A Vignale, Andrea Hernandez Garcia, Carlos P Modenutti, et al.
Nature Communications|July 17, 2024
Realization of a two-dimensional Weyl semimetal and topological Fermi stringsQiangsheng Lu, P V Sreenivasa Reddy, Hoyeon Jeon, et al.
Plos One|January 22, 2021
Incidence and characterization of acute pulmonary embolism in patients with SARS-CoV-2 pneumonia: A multicenter Italian experienceMarco Loffi, Valentina Regazzoni, Marco Toselli, et al.
Analytica Chimica Acta|August 12, 2023
Multi-analytical characterization of an oncoid from a high altitude hypersaline lake using techniques employed in the Mars2020 and Rosalind Franklin missions on MarsJ Huidobro, J M Madariaga, D Carrizo, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 20, 2025
Intravenous amino acids for renal protection in patients receiving temporary mechanical circulatory support: a secondary subgroup analysis of the PROTECTION studyAlessandro Belletti, Antonio Pisano, Anna Mara Scandroglio, et al.
NPJ Digital Medicine|January 3, 2026
Powering responsible artificial intelligence with high-quality real-world data: the S-RACE platform for scalable, multi-specialty clinical researchAlberto Traverso, Donato Tiano, Andrea Corvaglia, et al.
Plos One|November 22, 2017
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trialBarbara Rossetti, Roberta Gagliardini, Genny Meini, et al.
Journal of Clinical Medicine|June 2, 2021
The Spectrum of COVID-19-Associated Myocarditis: A Patient-Tailored Multidisciplinary ApproachGiovanni Peretto, Andrea Villatore, Stefania Rizzo, et al.
Pageof 27